Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2024 | Highlights from ACTRIMS 2024

Barry Singer, MD, The MS Center for Innovations in Care, St. Louis, MO, shares key insights from the annual ACTRIMS Forum 2024 in the multiple sclerosis (MS) space. He highlights the scalable precision medicine open knowledge engine (SPOKE) database, employing artificial intelligence to predict MS development three years before onset with 83% accuracy. Additionally, Dr Singer discusses innovative research screening compounds for remyelination therapy, including a unique method utilizing 3D-printed artificial axons to evaluate agent efficacy. This interview took place during the annual ACTRIMS Forum 2024.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.